☆ 4.7 Review

Clinical use of Molecular Data in Thyroid Nodules and Cancer

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Genomic and epigenomic profile of thyroid cancer

Adrian Acuna-Ruiz et al.

Summary: Thyroid cancer, the most common malignancy of the endocrine system, has seen increasing incidence. Recent advances in genomics and epigenomics have provided new insights into the development and progression of thyroid cancer, offering opportunities for further research and clinical treatment strategies.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Endocrinology & Metabolism

Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm

Susmita Dutta et al.

Summary: This proof-of-concept study shows that driver mutations in differentiated thyroid tumors can be detected in plasma, with a detection rate of up to 80% in malignant nodules. The use of an 8-gene panel can also predict cancer subtypes. There is strong agreement between driver mutations found in plasma samples, FNAC materials, and histopathology samples, indicating the potential for this noninvasive diagnostic tool in preoperative assessment and tumor recurrence detection.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis

Christian E. Nasr et al.

Summary: The Afirma GSC is effective in risk stratifying indeterminate thyroid nodule cytology. Real-world studies have shown improved performance of the GSC compared to the validation study, with higher sensitivity, negative predictive value, and lower false positive rate. This method can effectively increase the detection rate of suspicious nodules and reduce unnecessary surgeries.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Endocrinology & Metabolism

Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3

Na Eun Kim et al.

Summary: This study evaluated the performance of Afirma GSC and Thyroseq v3 in diagnosing indeterminate thyroid nodules and found that these molecular tests have a relatively low false negative rate, indicating their high sensitivity in ruling out malignancy.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Otorhinolaryngology

Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series

J. J. Y. Yeo et al.

Summary: This study discussed the use of tyrosine kinase inhibitors as neoadjuvant therapy in four patients with locally advanced differentiated thyroid cancer. The results showed that these inhibitors can effectively reduce the extent of the primary tumor and facilitate surgical resection for local disease control.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2023)

Add to Collection

Review Endocrinology & Metabolism

Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature

Douglas Van Nostrand et al.

Summary: Patients with metastatic differentiated thyroid cancer (mDTC) often have negative diagnostic and/or post-therapy radioiodine scans. However, with the knowledge of genomic alterations, selected agents may be used to promote I-131 uptake (i.e., redifferentiation) and additional therapy for these patients.

THYROID (2023)

Add to Collection

Review Oncology

Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review

Saruchi Bandargal et al.

Summary: This study investigated the relationship between PTEN mutations and thyroid malignancy, and whether these malignancies are aggressive. The results showed that 37.5% of PTEN-mutated thyroid nodules were malignant, and aggressive features were present in 33.33% of the malignant tumors. It is hypothesized that PTEN-mutated thyroid nodules can acquire high allele frequency and widespread copy number alterations over time, which may worsen the effects of PTEN mutations.

CANCERS (2023)

Add to Collection

Review Endocrinology & Metabolism

The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma

Fulvio Basolo et al.

Summary: The 5th edition of the WHO classification of endocrine tumors, released in 2022, introduces several novelties in the nomenclature and histopathological diagnosis of follicular-derived thyroid neoplasms. Tumor types are now categorized into benign tumors, low-risk neoplasms, and malignant neoplasms based on prognostic risk. A grading system for differentiated thyroid carcinomas has been implemented for better tumor stratification. The review critically discusses the practical effects on diagnostic pathology and the expected clinical implications of the new classification scheme.

ENDOCRINE (2023)

Add to Collection

Review Oncology

BRAF mutations in thyroid cancer

Rafael Selbach Scheffel et al.

Summary: This review discusses the impact of BRAF mutations on clinical features and treatment of thyroid cancer. The relationship between BRAF V600E mutation and poor prognosis is still debated, and further research is needed. The mechanisms of aggressiveness in BRAF-mutant thyroid cancer are not yet clear.

CURRENT OPINION IN ONCOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature Revision

Vikas Mehta et al.

Summary: The study compared the impact of management strategies for noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and encapsulated follicular variant of papillary thyroid carcinoma (eFVPTC) on healthcare costs and quality of life. The findings indicated that managing NIFTP resulted in cost savings and improved quality-adjusted life years compared to managing eFVPTC.

THYROID (2022)

Add to Collection

Review Otorhinolaryngology

Diagnostic performance of the second-generation molecular tests in the assessment of indeterminate thyroid nodules: A systematic review and meta-analysis

Esther Lee et al.

Summary: The objective of this systematic review and meta-analysis was to evaluate the diagnostic performance of second-generation molecular tests in diagnosing thyroid nodules with indeterminate fine-needle aspiration biopsy results. The pooled data showed that both Afirma GSC and Thyroseq v3 had high sensitivity and negative predictive value, indicating their potential to rule out malignancy in thyroid nodules.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma

Steven G. Waguespack et al.

Summary: This study evaluated the efficacy and safety of Larotrectinib in patients with TRK fusion-positive thyroid carcinoma. The results showed that Larotrectinib demonstrated rapid and durable disease control and a favorable safety profile in these patients, making it a potential treatment option for advanced thyroid carcinoma.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Add to Collection

Review Oncology

Mapping global epidemiology of thyroid nodules among general population: A systematic review and meta-analysis

Chunyang Mu et al.

Summary: This study investigates the global prevalence of thyroid nodules (TNs) among the general population. The results show that TNs are prevalent worldwide, regardless of country development and economic status. The prevalence of TNs has increased in recent years, with higher rates in women compared to men. Additionally, obesity is found to be correlated with the prevalence of TNs.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules

Sydney D. D. Finkelstein et al.

Summary: This study compares the accuracy of two different molecular testing methods for risk stratification of cytologically indeterminate thyroid nodules. The results show that the new method significantly improves diagnostic accuracy compared to the old method and reduces the size of the moderate-risk group. These findings are clinically important.

THYROID (2022)

Add to Collection

Review Oncology

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas

Marco De Martino et al.

Summary: Thyroid tumors are the most common neoplastic pathology of the endocrine system, with mutations in oncogenes and tumor suppressor genes playing a role in their development. Noncoding RNAs have been found to be crucial in regulating gene expression and tumor progression in thyroid cancer. Evaluating the noncoding RNA network could lead to a more personalized approach in the diagnosis, prognosis, and treatment of thyroid cancer.

CANCERS (2022)

Add to Collection

Review Oncology

Diagnostic performances of the Afirma gene sequencing classifier in comparison with the gene expression classifier: A meta-analysis

Huy Gia Vuong et al.

Summary: Compared with GEC, GSC showed higher BCR, lower RR, and higher ROM. The BCR of Hurthle cell-predominant nodules was significantly elevated, while the specificity and PPV of Afirma GSC were significantly improved, maintaining high sensitivity and NPV as well.

CANCER CYTOPATHOLOGY (2021)

Add to Collection

Article

Utilizing molecular testing to improve the management of thyroid nodules with indeterminate cytology: an institutional experience with review of molecular alterations

Ryan E. Glass et al.

Journal of the American Society of Cytopathology (2021)

Add to Collection

Article Oncology

Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules A Randomized Clinical Trial

Masha J. Livhits et al.

Summary: Both the RNA test and DNA-RNA test demonstrated high specificity and allowed more than half of patients with indeterminate nodules to avoid diagnostic surgery. There was no statistically significant difference in performance between the current molecular test techniques.

JAMA ONCOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know

Marco Volante et al.

Summary: In recent years, there has been significant progress in the molecular characterization of poorly and anaplastic thyroid carcinomas, with the impact of molecular pathology playing a multifaceted role in these tumors. The combination of genomic and epigenetic data reveals that many molecular alterations affect druggable cellular pathways in these tumors.

ENDOCRINE PATHOLOGY (2021)

Add to Collection

Article Oncology

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas

Meihua Jin et al.

Summary: Aggressive variants of papillary thyroid carcinoma (PTC) are associated with unfavorable clinical outcomes. Targeted next-generation sequencing in 36 tissue samples from patients with aggressive variants of PTC revealed a higher prevalence of BRAF mutation and lower prevalence of RAS mutation. The prevalence of mutations in the TERT promoter, TP53, and genes encoding three functional groups ranged between that of PTCs and poorly differentiated/anaplastic carcinoma.

CANCERS (2021)

Add to Collection

Article Endocrinology & Metabolism

Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing

Michiya Nishino et al.

Summary: Repeat FNA cytology can guide the selection of indeterminate thyroid nodules for molecular testing, reducing unnecessary surgical risks for benign nodules while only missing a few low-risk tumors.

THYROID (2021)

Add to Collection

Article Oncology

NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis

Barbora Pekova et al.

Summary: NTRK fusion genes are important yet understudied molecular markers in thyroid cancer. Identification of these genes can improve diagnosis and prognosis, and there are recommendations for surgery and prognostic factors for NTRK-rearranged tumors. Detection of NTRK fusion-positive carcinomas and their correlation with clinical data underscores their diagnostic and prognostic significance.

CANCERS (2021)

Add to Collection

Article Biology

Large contribution of copy number alterations in early stage of Papillary Thyroid Carcinoma

Nazanin Hosseinkhan et al.

Summary: This study conducted a comprehensive investigation on mutational and somatic copy number alterations in 277 stage I PTC, finding amplification and deletion of several cancer-related genes. Despite heterogeneity in SCNA events, the final results would be the activation/deactivation of a few cancer signaling pathways.

COMPUTERS IN BIOLOGY AND MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer

Chiara Romano et al.

Summary: Liquid biopsy is a non-invasive approach that can detect and analyze biological samples released from tumors into the bloodstream, providing valuable molecular information for defining diagnosis, estimating prognosis, and monitoring tumor recurrence or treatment response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Endocrinology & Metabolism

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

Vivek Subbiah et al.

Summary: Pralsetinib is a new, well-tolerated, potent once-daily oral treatment option for patients with RET-altered thyroid cancer, showing significant antitumor activity and good safety profile in patients with different types of RET alterations.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Genetics, Diagnosis, and Management of Hurthle Cell Thyroid Neoplasms

David G. McFadden et al.

Summary: Hurthle cell lesions have been a diagnostic challenge in pathology due to controversies surrounding the cell's name, origin, and diagnosis. Despite advancements in molecular genetics and testing, the diagnosis of Hurthle cell tumors remains challenging.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application

Sule Canberk et al.

Summary: Cancer genomes often have alterations to the epigenome, including silencing of tumor suppressor genes. Epigenetic changes play a significant role in the differentiation and proliferation of thyroid follicular cells. However, research on the role of epigenomics in Hurthle cell neoplasms still faces limitations.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Update on Targeted Therapy in Medullary Thyroid Cancer

Christian Okafor et al.

Summary: Medullary thyroid carcinoma is a rare neuroendocrine tumor linked to RET gene mutations. The development of new RET-targeting therapies provides effective options for treatment, but resistance remains a challenge.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer

Tanner Fullmer et al.

Summary: Advancements in understanding the molecular basis of thyroid function and carcinogenesis have led to the development of novel therapeutic options for iodine-resistant thyroid cancer, significantly improving the prognostic outlook for patients. FDA-approved tyrosine kinase inhibitors and small molecular inhibitors target various pathways to re-sensitize de-differentiated cancers to iodine treatment and have even provided treatment options for previously considered fatal mutations like BRAF in anaplastic thyroid cancer. The treatment landscape for iodine-resistant thyroid cancer is rapidly evolving with new targets, therapies, clinical trials, and approved treatments.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Oncology

Translational Utility of Liquid Biopsies in Thyroid Cancer Management

Ayanthi A. Wijewardene et al.

Summary: Liquid biopsies are a novel technique that assess for circulating tumor cells (CTC), circulating tumor DNA (ctDNA), and microRNA in peripheral blood samples of cancer patients. The diagnostic role of liquid biopsy in oncology has expanded in recent years, especially in lung, colorectal, and breast cancer. In thyroid cancer, liquid biopsy's role in diagnosis or prognosis is transitioning from the lab to clinical practice.

CANCERS (2021)

Add to Collection

Article Oncology

Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas

Luuk Harbers et al.

Summary: SCNAs are a common feature of human cancers, affecting the dosage of multiple genes and promoting tumorigenesis. A comprehensive analysis of 853,218 SCNAs from 10,729 tumor samples across 32 cancer types using TCGA data was conducted, discussing current models for their generation during carcinogenesis and their clinical implications, while also highlighting unresolved questions in the field.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Surgery

Thyroid nodules with indeterminate cytology: association between nodule size, histopathological characteristics and clinical outcome in differentiated thyroid carcinomas - a multicenter retrospective cohort study on 761 patients

Federico Cozzani et al.

Summary: A study of 761 patients undergoing thyroid surgery for undetermined nodules revealed that nodule size did not correlate significantly with malignancy rate, histological characteristics, or patient outcomes. Most tumors identified were low-risk follicular pattern with good treatment response and survival outcomes. Overtreatment may result from selecting surgical approaches based solely on nodule size in the absence of other risk factors.

UPDATES IN SURGERY (2021)

Add to Collection

Review Genetics & Heredity

RET Gene Fusions in Malignancies of the Thyroid and Other Tissues

Massimo Santoro et al.

GENES (2020)

Add to Collection

Article Medical Laboratory Technology

Multiplatform molecular test performance in indeterminate thyroid nodules

Mark A. Lupo et al.

DIAGNOSTIC CYTOPATHOLOGY (2020)

Add to Collection

Article Oncology

The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample

Jeffrey F. Krane et al.

CANCER CYTOPATHOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy

Kirk Jensen et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Review Medical Laboratory Technology

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances

Ying-Hsia Chu et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

L. J. Wirth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The role of microRNAs in the pathogenesis of thyroid cancer

Soudeh Ghafouri-Fard et al.

NON-CODING RNA RESEARCH (2020)

Add to Collection

Article Endocrinology & Metabolism

RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP)

Mara Ventura et al.

ENDOCRINE PRACTICE (2019)

Add to Collection

Review Endocrinology & Metabolism

Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects

Tihana Ibrahimpasic et al.

THYROID (2019)

Add to Collection

Article Endocrinology & Metabolism

Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules

Trevor E. Angell et al.

THYROID (2019)

Add to Collection

Article Pathology

Mutation profiles of follicular thyroid tumors by targeted sequencing

Huanli Duan et al.

DIAGNOSTIC PATHOLOGY (2019)

Add to Collection

Review Oncology

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians

Pedro Weslley Rosario et al.

ENDOCRINE-RELATED CANCER (2019)

Add to Collection

Article Endocrinology & Metabolism

Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy

Guoquan Zhu et al.

ENDOCRINE CONNECTIONS (2019)

Add to Collection

Review Endocrinology & Metabolism

Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis

Massimo Bongiovanni et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules

Mayumi Endo et al.

THYROID (2019)

Add to Collection

Review Endocrinology & Metabolism

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond

Maria E. Cabanillas et al.

ENDOCRINE REVIEWS (2019)

Add to Collection

Article Oncology

Characterization of thyroid cancer driven by known and novel ALK fusions

Federica Panebianco et al.

ENDOCRINE-RELATED CANCER (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in Clinics

Celeste Caruso Bavisotto et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Endocrinology & Metabolism

Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis

Kristina J. Nicholson et al.

THYROID (2019)

Add to Collection

Review Genetics & Heredity

Thyroid Cancer in the Pediatric Population

Vera A. Paulson et al.

GENES (2019)

Add to Collection

Article Endocrinology & Metabolism

Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples

Trevor E. Angell et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Add to Collection

Review Surgery

Approach to cytological indeterminate thyroid nodules

Massimo Bongiovanni et al.

GLAND SURGERY (2019)

Add to Collection

Article Oncology

Benign call rate and molecular test result distribution of ThyroSeq v3

N. Paul Ohori et al.

CANCER CYTOPATHOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

COSMIC: the Catalogue Of Somatic Mutations In Cancer

John G. Tate et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Oncology

EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

Gnana P. Krishnamoorthy et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Oncology

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology A Prospective Blinded Multicenter Study

David L. Steward et al.

JAMA ONCOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population

Andre Uchimura Bastos et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

Add to Collection

Article Oncology

Analytical Performance of the ThyroSeq v3 Genomic Classifier for Cancer Diagnosis in Thyroid Nodules

Marina N. Nikiforova et al.

CANCER (2018)

Add to Collection

Article Cell Biology

Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer

Zhong-Ling Qiu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Add to Collection

Article Oncology

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

Nikita Pozdeyev et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Oncology

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Vivek Subbiah et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Cell Biology

Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer

Thanyawat Sasanakietkul et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Add to Collection

Review Endocrinology & Metabolism

Gene Fusions in Thyroid Cancer

Valentina D. Yakushina et al.

THYROID (2018)

Add to Collection

Article Multidisciplinary Sciences

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

Rengyun Liu et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Surgery

Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules

Kepal N. Patel et al.

JAMA SURGERY (2018)

Add to Collection

Article Oncology

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

Fei Wang et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Cell Biology

Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors

Sadegh Saghafinia et al.

CELL REPORTS (2018)

Add to Collection

Article Endocrinology & Metabolism

Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma

Gilbert J. Cote et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Add to Collection

Article Oncology

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

Maria E. Cabanillas et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Endocrinology & Metabolism

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis

Shinje Moon et al.

THYROID (2017)

Add to Collection

Article Endocrinology & Metabolism

The 2017 Bethesda System for Reporting Thyroid Cytopathology

Edmund S. Cibas et al.

THYROID (2017)

Add to Collection

Review Endocrinology & Metabolism

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Bryan R. Haugen et al.

THYROID (2017)

Add to Collection

Review Oncology

Molecular cytopathology for thyroid nodules: A review of methodology and test performance

Michiya Nishino

CANCER CYTOPATHOLOGY (2016)

Add to Collection

Article Oncology

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients

Young Shin Song et al.

CANCER (2016)

Add to Collection

Review Pharmacology & Pharmacy

Effects and Role of Multikinase Inhibitors in Thyroid Cancer

Rasmus Laursen et al.

CURRENT PHARMACEUTICAL DESIGN (2016)

Add to Collection

Article Endocrinology & Metabolism

LONG-TERM NONOPERATIVE RATE OF THYROID NODULES WITH BENIGN RESULTS ON THE AFIRMA GENE EXPRESSION CLASSIFIER

Jennifer A. Sipos et al.

ENDOCRINE PRACTICE (2016)

Add to Collection

Review Oncology

TERT promoter mutations in thyroid cancer

Rengyun Liu et al.

ENDOCRINE-RELATED CANCER (2016)

Add to Collection

Letter Oncology

Genetic variants in thyroid cancer distant metastases

Steven E. Justiniano et al.

ENDOCRINE-RELATED CANCER (2016)

Add to Collection

Article Endocrinology & Metabolism

Subclonality for BRAF Mutation in Papillary Thyroid Carcinoma Is Associated With Earlier Disease Stage

Alona Finkel et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Add to Collection

Article Medicine, Research & Experimental

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Inigo Lancia et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Add to Collection

Review Endocrinology & Metabolism

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

Cristina Romei et al.

NATURE REVIEWS ENDOCRINOLOGY (2016)

Add to Collection

Review Medicine, General & Internal

Biologic and Clinical Perspectives on Thyroid Cancer

James A. Fagin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Endocrinology & Metabolism

Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer

Seo Young Sohn et al.

THYROID (2016)

Add to Collection

Article Endocrinology & Metabolism

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Bryan R. Haugen et al.

THYROID (2016)

Add to Collection

Review Oncology

TERT Promoter Mutations in Thyroid Cancer

Ali S. Alzahrani et al.

HORMONES & CANCER (2016)

Add to Collection

Article Oncology

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis

Fei Li et al.

ENDOCRINE-RELATED CANCER (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing

John W. Kunstman et al.

HUMAN MOLECULAR GENETICS (2015)

Add to Collection

Article Oncology

Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

Mingzhao Xing et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Review Biochemistry & Molecular Biology

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

Yu Sun et al.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)

Add to Collection

Article Medicine, General & Internal

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Endocrinology & Metabolism

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

Yuri E. Nikiforov et al.

THYROID (2015)

Add to Collection

Article Oncology

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

Maria E. R. Garcia-Rendueles et al.

CANCER DISCOVERY (2015)

Add to Collection

Article Oncology

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma

Lauren E. Henke et al.

CANCER MEDICINE (2015)

Add to Collection

Article Oncology

Highly Accurate Diagnosis of Cancer in Thyroid Nodules With Follicular Neoplasm/Suspicious for a Follicular Neoplasm Cytology by ThyroSeq v2 Next-Generation Sequencing Assay

Yuri E. Nikiforov et al.

CANCER (2014)

Add to Collection

Review Oncology

The MAPK Pathway Across Different Malignancies: A New Perspective

Mauricio Burotto et al.

CANCER (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal et al.

CELL (2014)

Add to Collection

Article Medicine, General & Internal

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Marcia S. Brose et al.

LANCET (2014)

Add to Collection

Article Endocrinology & Metabolism

PAX8/PPARγ Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma

Michaele J. Armstrong et al.

THYROID (2014)

Add to Collection

Article Endocrinology & Metabolism

The BRAFV600E Mutation Influences the Short- and Medium-Term Outcomes of Classic Papillary Thyroid Cancer, But Is Not an Independent Predictor of Unfavorable Outcome

Marco Russo et al.

THYROID (2014)

Add to Collection

Article Cell Biology

Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases

Laura A. Boos et al.

HISTOPATHOLOGY (2013)

Add to Collection

Article Medicine, General & Internal

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

Mingzhao Xing et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Add to Collection

Article Endocrinology & Metabolism

Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer

Marina N. Nikiforova et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Add to Collection

Article Oncology

RAS Mutations in Thyroid Cancer

Gina M. Howell et al.

ONCOLOGIST (2013)

Add to Collection

Review Oncology

Molecular pathogenesis and mechanisms of thyroid cancer

Mingzhao Xing

NATURE REVIEWS CANCER (2013)

Add to Collection

Article Oncology

The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer

Tae Hyuk Kim et al.

CANCER (2012)

Add to Collection

Article Endocrinology & Metabolism

The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma

Anna Guerra et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Add to Collection

Review Medicine, General & Internal

BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment A Systematic Review and Meta-Analysis

Ralph P. Tufano et al.

MEDICINE (2012)

Add to Collection

Article Medicine, General & Internal

Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology

Erik K. Alexander et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Endocrinology & Metabolism

The Associations Between RAS Mutations and Clinical Characteristics in Follicular Thyroid Tumors: New Insights from a Single Center and a Large Patient Cohort

Michiko Fukahori et al.

THYROID (2012)

Add to Collection

Article Endocrinology & Metabolism

The Impact of Benign Gene Expression Classifier Test Results on the Endocrinologist-Patient Decision to Operate on Patients with Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytopathology

Daniel S. Duick et al.

THYROID (2012)

Add to Collection

Article Endocrinology & Metabolism

The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland

Iain J. Nixon et al.

THYROID (2012)

Add to Collection

Editorial Material Cell Biology

PI3K-PKB/Akt Pathway

Brian A. Hemmings et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Levels of histone acetylation in thyroid tumors

Cinzia Puppin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Add to Collection

Article Oncology

DNA Copy Number Alterations in Radiation-induced Thyroid Cancer

H. Zitzelsberger et al.

CLINICAL ONCOLOGY (2011)

Add to Collection

Article Endocrinology & Metabolism

Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

Yuri E. Nikiforov et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Add to Collection

Article Cell Biology

TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use

Magali Olivier et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)

Add to Collection

Article Oncology

Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1

Julio C. Ricarte-Filho et al.

CANCER RESEARCH (2009)

Add to Collection

Article Medicine, General & Internal

Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination

S. Guth et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)

Add to Collection

Article Endocrinology & Metabolism

RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact

Marco Volante et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Add to Collection

Article Endocrinology & Metabolism

Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules

Yuri E. Nikiforov et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Add to Collection

Article Multidisciplinary Sciences

V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway

Christine A. Pratilas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Add to Collection

Article Endocrinology & Metabolism

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers

Zhi Liu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Add to Collection

Review Medicine, General & Internal

Molecular origins of cancer: Epigenetics in cancer

Manel Esteller

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

Review Endocrinology & Metabolism

BRAF mutation in papillary thyroid cancer:: Pathogenic role, molecular bases, and clinical implications

Mingzhao Xing

ENDOCRINE REVIEWS (2007)

Add to Collection

Article Oncology

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer

Peng Hou et al.

CLINICAL CANCER RESEARCH (2007)

Add to Collection

Review Endocrinology & Metabolism

Minireview: AKT in thyroid tumorigenesis and progression

Motoo Shinohara et al.

ENDOCRINOLOGY (2007)

Add to Collection

Review Cell Biology

Global patterns of histone modifications

Oliver J. Rando

CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)

Add to Collection

Article Endocrinology & Metabolism

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy

C. Durante et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Add to Collection

Article Pathology

Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas

AJ Adeniran et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)

Add to Collection

Article Endocrinology & Metabolism

PAX8-PPAR gamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma

P Castro et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Add to Collection

Article Oncology

BRAF mutation in papillary thyroid carcinoma

J Cohen et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

Add to Collection

Article Pathology

PAX8-PPARγ rearrangement in thyroid tumors -: RT-PCR and immunohistochemical analyses

MN Nikiforova et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)

Add to Collection

Review Multidisciplinary Sciences

The sequence of the human genome

JC Venter et al.

SCIENCE (2001)

Add to Collection

Review Multidisciplinary Sciences

Initial sequencing and analysis of the human genome

ES Lander et al.

NATURE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.